• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

基于 MRI 的放射组学模型评估直肠癌新辅助放化疗的治疗反应。

Evaluating treatment response to neoadjuvant chemoradiotherapy in rectal cancer using various MRI-based radiomics models.

机构信息

Department of Radiology, Changhai Hospital, No.168 Changhai Road, Shanghai, 200433, China.

Huiying Medical Technology Co., Ltd, Beijing, China.

出版信息

BMC Med Imaging. 2021 Feb 16;21(1):30. doi: 10.1186/s12880-021-00560-0.

DOI:10.1186/s12880-021-00560-0
PMID:33593304
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC7885409/
Abstract

BACKGROUND

To validate and compare various MRI-based radiomics models to evaluate treatment response to neoadjuvant chemoradiotherapy (nCRT) of rectal cancer.

METHODS

A total of 80 patients with locally advanced rectal cancer (LARC) who underwent surgical resection after nCRT were enrolled retrospectively. Rectal MR images were scanned pre- and post-nCRT. The radiomics features were extracted from T2-weighted images, then reduced separately by least absolute shrinkage and selection operator (LASSO) and principal component analysis (PCA). Four classifiers of Logistic Regression, Random Forest (RF), Decision Tree and K-nearest neighbor (KNN) models were constructed to assess the tumor regression grade (TRG) and pathologic complete response (pCR), respectively. The diagnostic performances of models were determined with leave-one-out cross-validation by generating receiver operating characteristic curves and decision curve analysis.

RESULTS

Three features related to the TRG and 11 features related to the pCR were obtained by LASSO. Top five principal components representing a cumulative contribution of 80% to overall features were selected by PCA. For TRG, the area under the curve (AUC) of RF model was 0.943 for LASSO and 0.930 for PCA, higher than other models (P < 0.05 for both). As for pCR, the AUCs of KNN for LASSO and PCA were 0.945 and 0.712, higher than other models (P < 0.05 for both). The DCA showed that LASSO algorithm was clinically superior to PCA.

CONCLUSION

MRI-based radiomics models demonstrated good performance for evaluating the treatment response of LARC after nCRT and LASSO algorithm yielded more clinical benefit.

摘要

背景

为了验证和比较各种基于 MRI 的放射组学模型,以评估新辅助放化疗(nCRT)治疗直肠癌的治疗反应。

方法

回顾性纳入 80 例接受 nCRT 后行手术切除的局部进展期直肠癌(LARC)患者。对 nCRT 前后的直肠磁共振成像(MRI)进行扫描。从 T2 加权图像中提取放射组学特征,然后分别通过最小绝对值收缩和选择算子(LASSO)和主成分分析(PCA)进行降维。构建逻辑回归、随机森林(RF)、决策树和 K 最近邻(KNN)模型等四种分类器,分别评估肿瘤退缩分级(TRG)和病理完全缓解(pCR)。通过生成接受者操作特征曲线和决策曲线分析,采用留一交叉验证法确定模型的诊断性能。

结果

LASSO 获得了与 TRG 相关的 3 个特征和与 pCR 相关的 11 个特征。PCA 选择了代表总体特征 80%累积贡献的前 5 个主成分。对于 TRG,LASSO 模型的 RF 曲线下面积(AUC)为 0.943,PCA 为 0.930,均高于其他模型(均 P<0.05)。对于 pCR,LASSO 和 PCA 的 KNN 的 AUC 分别为 0.945 和 0.712,均高于其他模型(均 P<0.05)。DCA 显示 LASSO 算法具有更高的临床获益。

结论

基于 MRI 的放射组学模型在评估 nCRT 治疗 LARC 后的治疗反应方面表现良好,LASSO 算法具有更高的临床获益。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/005b/7885409/e05715ce07b1/12880_2021_560_Fig7_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/005b/7885409/b21360990c30/12880_2021_560_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/005b/7885409/760ece06fa95/12880_2021_560_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/005b/7885409/17fc142bda9e/12880_2021_560_Fig3_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/005b/7885409/43baf4d5f5a1/12880_2021_560_Fig4_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/005b/7885409/04f1b3d7d683/12880_2021_560_Fig5_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/005b/7885409/8bb61fbfaf1e/12880_2021_560_Fig6_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/005b/7885409/e05715ce07b1/12880_2021_560_Fig7_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/005b/7885409/b21360990c30/12880_2021_560_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/005b/7885409/760ece06fa95/12880_2021_560_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/005b/7885409/17fc142bda9e/12880_2021_560_Fig3_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/005b/7885409/43baf4d5f5a1/12880_2021_560_Fig4_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/005b/7885409/04f1b3d7d683/12880_2021_560_Fig5_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/005b/7885409/8bb61fbfaf1e/12880_2021_560_Fig6_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/005b/7885409/e05715ce07b1/12880_2021_560_Fig7_HTML.jpg

相似文献

1
Evaluating treatment response to neoadjuvant chemoradiotherapy in rectal cancer using various MRI-based radiomics models.基于 MRI 的放射组学模型评估直肠癌新辅助放化疗的治疗反应。
BMC Med Imaging. 2021 Feb 16;21(1):30. doi: 10.1186/s12880-021-00560-0.
2
Radiomics analysis of multiparametric MRI for prediction of pathological complete response to neoadjuvant chemoradiotherapy in locally advanced rectal cancer.多参数 MRI 的放射组学分析预测局部晚期直肠癌新辅助放化疗的病理完全缓解。
Eur Radiol. 2019 Mar;29(3):1211-1220. doi: 10.1007/s00330-018-5683-9. Epub 2018 Aug 20.
3
Machine learning-based response assessment in patients with rectal cancer after neoadjuvant chemoradiotherapy: radiomics analysis for assessing tumor regression grade using T2-weighted magnetic resonance images.基于机器学习的新辅助放化疗后直肠癌患者的疗效评估:利用 T2 加权磁共振成像评估肿瘤退缩分级的影像组学分析。
Int J Colorectal Dis. 2024 May 24;39(1):78. doi: 10.1007/s00384-024-04651-6.
4
Predicting pathological complete response by comparing MRI-based radiomics pre- and postneoadjuvant radiotherapy for locally advanced rectal cancer.基于 MRI 的放射组学比较新辅助放疗前后预测局部晚期直肠癌的病理完全缓解。
Cancer Med. 2019 Dec;8(17):7244-7252. doi: 10.1002/cam4.2636. Epub 2019 Oct 22.
5
MRI Radiomics Model Predicts Pathologic Complete Response of Rectal Cancer Following Chemoradiotherapy.MRI影像组学模型预测直肠癌放化疗后的病理完全缓解情况。
Radiology. 2022 May;303(2):351-358. doi: 10.1148/radiol.211986. Epub 2022 Feb 8.
6
External validation and comparison of MR-based radiomics models for predicting pathological complete response in locally advanced rectal cancer: a two-centre, multi-vendor study.基于磁共振成像的影像组学模型预测局部晚期直肠癌病理完全缓解的外部验证与比较:一项双中心、多设备研究
Eur Radiol. 2023 Mar;33(3):1906-1917. doi: 10.1007/s00330-022-09204-5. Epub 2022 Nov 10.
7
MRI-based delta-radiomics are predictive of pathological complete response after neoadjuvant chemoradiotherapy in locally advanced rectal cancer.基于 MRI 的 delta 放射组学可预测局部晚期直肠癌新辅助放化疗后的病理完全缓解。
Acad Radiol. 2021 Nov;28 Suppl 1:S95-S104. doi: 10.1016/j.acra.2020.10.026. Epub 2020 Nov 12.
8
Machine learning-based multiparametric MRI radiomics for predicting poor responders after neoadjuvant chemoradiotherapy in rectal Cancer patients.基于机器学习的多参数 MRI 放射组学预测直肠癌患者新辅助放化疗后无应答者。
BMC Cancer. 2022 Apr 19;22(1):420. doi: 10.1186/s12885-022-09518-z.
9
Radiomics of MRI for pretreatment prediction of pathologic complete response, tumor regression grade, and neoadjuvant rectal score in patients with locally advanced rectal cancer undergoing neoadjuvant chemoradiation: an international multicenter study.MRI 放射组学预测局部晚期直肠癌新辅助放化疗后病理完全缓解、肿瘤退缩分级和新辅助直肠评分的价值:一项国际多中心研究。
Eur Radiol. 2020 Nov;30(11):6263-6273. doi: 10.1007/s00330-020-06968-6. Epub 2020 Jul 14.
10
Selecting Candidates for Organ-Preserving Strategies After Neoadjuvant Chemoradiotherapy for Rectal Cancer: Development and Validation of a Model Integrating MRI Radiomics and Pathomics.选择新辅助放化疗后保留器官策略的候选者:整合 MRI 放射组学和病理组学的模型的开发和验证。
J Magn Reson Imaging. 2022 Oct;56(4):1130-1142. doi: 10.1002/jmri.28108. Epub 2022 Feb 10.

引用本文的文献

1
Benchmarking feature projection methods in radiomics.放射组学中特征投影方法的基准测试
Sci Rep. 2025 Sep 5;15(1):32368. doi: 10.1038/s41598-025-16070-w.
2
Can Radiomics Predict Pathologic Complete Response After Neoadjuvant Chemoradiotherapy for Rectal Cancer? A Systematic Review and Meta-Analysis of Diagnostic-Accuracy Studies.放射组学能否预测直肠癌新辅助放化疗后的病理完全缓解?诊断准确性研究的系统评价和荟萃分析。
J Pers Med. 2025 Jun 10;15(6):244. doi: 10.3390/jpm15060244.
3
Reliability of rectal MRI radiomic features: Comparing rectal MRI radiomic features across reader expertise levels, image segmentation technique, and timing of rectal MRI in patients with locally advanced rectal cancer.
直肠MRI影像组学特征的可靠性:比较局部晚期直肠癌患者中不同阅片者专业水平、图像分割技术及直肠MRI检查时间点的直肠MRI影像组学特征。
Eur J Radiol. 2025 Apr;185:112019. doi: 10.1016/j.ejrad.2025.112019. Epub 2025 Feb 26.
4
Image-based artificial intelligence for the prediction of pathological complete response to neoadjuvant chemoradiotherapy in patients with rectal cancer: a systematic review and meta-analysis.基于图像的人工智能在预测直肠癌新辅助放化疗病理完全缓解中的应用:系统评价和荟萃分析。
Radiol Med. 2024 Apr;129(4):598-614. doi: 10.1007/s11547-024-01796-w. Epub 2024 Mar 21.
5
Accuracy of deep neural learning models in the imaging prediction of pathological complete response after neoadjuvant chemoradiotherapy for locally advanced rectal cancer: a systematic review.深度神经网络学习模型在预测局部晚期直肠癌新辅助放化疗后病理完全缓解中的影像表现的准确性:一项系统评价。
Langenbecks Arch Surg. 2023 Aug 18;408(1):321. doi: 10.1007/s00423-023-03039-4.
6
The Role of Radiomics in Rectal Cancer.直肠癌的放射组学特征。
J Gastrointest Cancer. 2023 Dec;54(4):1158-1180. doi: 10.1007/s12029-022-00909-w. Epub 2023 May 8.
7
MRI-based pre-Radiomics and delta-Radiomics models accurately predict the post-treatment response of rectal adenocarcinoma to neoadjuvant chemoradiotherapy.基于磁共振成像(MRI)的放射组学前期模型和增量放射组学模型能够准确预测直肠腺癌对新辅助放化疗的治疗后反应。
Front Oncol. 2023 Feb 22;13:1133008. doi: 10.3389/fonc.2023.1133008. eCollection 2023.
8
Application of Radiomics in Predicting Treatment Response to Neoadjuvant Chemoradiotherapy in Locally Advanced Rectal Cancer: Strategies and Challenges.放射组学在预测局部晚期直肠癌新辅助放化疗治疗反应中的应用:策略与挑战
J Oncol. 2022 Nov 26;2022:1590620. doi: 10.1155/2022/1590620. eCollection 2022.
9
MRI-Based Radiomics Features to Predict Treatment Response to Neoadjuvant Chemotherapy in Locally Advanced Rectal Cancer: A Single Center, Prospective Study.基于MRI的影像组学特征预测局部晚期直肠癌新辅助化疗的治疗反应:一项单中心前瞻性研究
Front Oncol. 2022 May 12;12:801743. doi: 10.3389/fonc.2022.801743. eCollection 2022.
10
Automated Prediction of the Response to Neoadjuvant Chemoradiotherapy in Patients Affected by Rectal Cancer.直肠癌患者新辅助放化疗反应的自动化预测
Cancers (Basel). 2022 Apr 29;14(9):2231. doi: 10.3390/cancers14092231.